MS
EPIX

Maven Securities’s ESSA Pharma EPIX Stock Holding History

Maven Securities’s Portfolio EPIX Stock Details EPIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-17,711
Closed -$512K – 1114
2021
Q2 		$512K Sell
17,711
-10,368
-37% -$301K 0.02% 635
2021
Q1 		$840K Sell
28,079
-6,721
-19% -$156K 0.04% 476
2020
Q4 		$415K Buy
+34,800
New +$245K 0.04% 382

Other funds holding EPIX

BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $32.9B AUM 23.66% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return

Maven Securities's EPIX Position: Q3 2021 in Review

Maven Securities sold out of ESSA Pharma (EPIX) in Q3 2021, closing a stake of 17,711 shares — an estimated $512K sold.

Maven Securities first reported a position in EPIX in Q4 2020 and held it in 3 quarters. The position peaked at $840K in Q1 2021. 75 funds tracked by Wall St. Rank hold EPIX as of Q3 2021.

  • Maven Securities reported no remaining ESSA Pharma position as of Q3 2021 after selling out during the quarter.
  • Maven Securities sold 17,711 ESSA Pharma shares in Q3 2021, an estimated $512K.
  • Maven Securities first reported a position in ESSA Pharma in Q4 2020 and held it in 3 quarters.
  • Maven Securities's ESSA Pharma position peaked at $840K in Q1 2021.
  • 75 funds tracked by Wall St. Rank held ESSA Pharma as of Q3 2021.

Based on Maven Securities's 13F filing for Q3 2021, filed 15 Nov 2021.